How do clinical features mechanistically relate to true vs. false positive MOG-IgG results?

OPEN

The TRUE-MOGAD score uses clinical variables to distinguish true from false positives, but the biological basis for why certain clinical presentations correlate with authentic MOG antibody pathogenicity remains unexplained. This knowledge gap limits understanding of MOGAD pathophysiology. Gap type: unexplained_observation Source paper: TRUE-MOGAD Score: A Novel Scoring System to Identify MOGAD Among Positive MOG-IgG Test Results. (2026, Neurol Neuroimmunol Neuroinflamm, PMID:41921125)

Priority: 0.73 Domain: neuroinflammation Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How do clinical features mechanistically relate to true vs. false positive MOG-IgG results? is a 0.73 priority gap in neuroinflammation. It has 0 linked hypotheses with average composite score 0.000. Status: open.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How do clinical features mechanistically relate to true vs. false positive MOG-IgG results? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
0%
Resolution
0
Mechanistic Families
Gap Resolution Progress0%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)

No hypotheses linked to this gap yet.

🌊 Knowledge Graph Connections

activates (1)

MOG-IgGFcγR

associated with (2)

MOG-IgGImmune-Mediated MyelopathiesMOG-IgGimmune-mediated myelopathy

biomarker for (1)

MOG-IgGMyelitis

causes (1)

MOG-IgGspinal cord demyelination

interacts with (1)

MOGMOG-IgG

mediates (1)

MOG-IgGmyelitis pathophysiology
🕑 Activity Feed

No activity recorded yet.

💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps